antibody-chopping drug

Actionable Insights Powered by AI

Patient with Preexisting Immunity to AAV Vectors Granted Gene Therapy After Antibody-Depleting Agent Allowed Eligibility

gene therapy; AAV antibodies; ineligible; antibody-chopping drug; clinical trial; eligibility